Related Experiment Videos
Antithrombin deficiency in special clinical syndromes--Part II: hematologic malignancies and bone marrow
1Section of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE 68198-3330, USA.
Seminars in Hematology
|October 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Techniques in dosing for thrombolysis of occluded central venous catheters.
Techniques in vascular and interventional radiology·2002
Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations.
Bone marrow transplantation·2002
Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.
Journal of vascular and interventional radiology : JVIR·2001
The multiple organ dysfunction syndrome in cancer patients undergoing hematopoietic stem cell transplantation.
Seminars in thrombosis and hemostasis·1999
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·1999
Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.
Seminars in hematology·2026
The current state of cerebral complications of sickle cell disease.
Seminars in hematology·2026
Germline predisposition in myeloproliferative neoplasms.
Seminars in hematology·2026
A ratiometric dual "turn-on" electrochemical strategy for reliable HbA1c level determination.
Chemical communications (Cambridge, England)·2026
Subarachnoid haemorrhage in paediatric hereditary haemorrhagic telangiectasia: a case report and literature review.
British journal of neurosurgery·2026